Findings from the phase 3 ADAPT SERON trial demonstrated that efgartigimod IV significantly improved MG-ADL total scores in patients who were acetylcholine receptor antibody seronegative. The Food and ...

Bariatric surgery rates rose gradually while GLP-1 receptor agonist prescriptions grew exponentially from 2018 to 2025.

For adults with severe scabies, higher-dose ivermectin plus permethrin is not superior to standard-dose ivermectin plus permethrin, according to a study published in the May 7 issue of the New England ...

Replacing universal vaccination with targeted birth-dose vaccine recommendation likely to result in increase in infections ...

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

Ozempic tablets are now available; investigational ALS treatment gains FDA Fast Track status; positive results for aficamten ...

Based on the current evidence, there is no consistent association between vaccines and serious or long-term health outcomes.

Tazbentetol is an investigational, once-daily synaptic regenerative therapy designed to restore cognitive and motor function in ALS.

HealthDay News — As an investigation continues into a hantavirus outbreak that killed three passengers and sickened five on an ocean liner, the World Health Organization (WHO) says the odds of broader ...

Relative vaccine efficacy was 26.6 percent, which met the criteria for noninferiority, superiority, higher-level superiority.

Topline data from the ACACIA-HCM study reveal that the cardiac myosin inhibitor aficamten met all primary and key secondary endpoints, offering a potential new treatment pathway for patients with ...

The approval is supported by bioequivalence data assessing the once-daily extended-release formulation to twice-daily immediate-release ruxolitinib in healthy participants.